about
Adenosine receptors as therapeutic targetsInteractions of flavones and other phytochemicals with adenosine receptorsThe A3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteinsAllosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivativesNeoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosidesRing-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5'-uronamide and 2'-deoxy modificationsConstitutive activation of A(3) adenosine receptors by site-directed mutagenesisResistance of muscle to tumor metastases: a role for a3 adenosine receptor agonistsStructure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptorsPharmacological characterization of novel A3 adenosine receptor-selective antagonistsPyran Template Approach to the Design of Novel A3 Adenosine Receptor AntagonistsStructure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptorActivation of the A2A adenosine receptor inhibits nitric oxide production in glial cells.Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.Mice lacking Melanin Concentrating Hormone 1 receptor are resistant to seizuresA3-adenosine receptors: design of selective ligands and therapeutic prospectsAdenosine and neurotrauma: therapeutic perspectives.Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells.Regulation of neurite outgrowth by G(i/o) signaling pathways.A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion.Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse.N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.Adenosine A3 receptors: novel ligands and paradoxical effects.A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.Adenosine receptor agonists: from basic medicinal chemistry to clinical development.Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.Tissue distribution of adenosine receptor mRNAs in the rat.Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.The role of ATP and adenosine in the brain under normoxic and ischemic conditions
P2860
Q24632095-94C4A45F-0E64-460B-A839-58AC5CDD69B1Q28207053-F9E63437-1F24-4745-85E7-0E42C8B5CA6BQ28344385-260D47C5-BFAC-4061-B31B-5FD281A1E995Q28362220-FEFAEAD8-9D5E-4F5C-BC2D-9044575673C6Q28364092-FC9D347C-EA97-46AB-9DA1-D25328141F4EQ28366377-1DF2A5DB-8358-480F-A285-899584464982Q28366534-A6D8646D-0DFD-4641-A0FA-0E6FC17F7017Q28367463-12DF43E9-EEE3-4496-89B9-BCD9D6ACFD5EQ28368377-51498811-9735-4F85-AE85-E7762F445F95Q28369020-8FD914A7-BA41-4246-8132-FB6F0965ED97Q28379206-2E7D5CE6-AC61-409C-967F-0CD4392CB087Q28834245-D5E9DBAE-3A71-4477-AA9D-2260F93297BDQ30424542-1852D83C-0163-4875-9341-775197C933DBQ30424626-49A55B6F-DAE2-4789-9A62-393826EDB948Q30431164-DB2A4E9E-AAD8-4689-96AC-44099D8ACD46Q33516043-C264657D-1B4E-4962-926C-467E3E8FF86FQ33754565-620E5BDB-AB30-4BC3-B3F4-33FE133708AAQ33797583-59428A11-D9C7-4EF4-83BC-41A93A66289CQ33834162-3C948A32-F7A6-4ADB-9467-FFE589BF1CCEQ33926350-B5BBF204-B18F-449B-BA3D-C66D256898D6Q33989019-8455CE1C-8071-4B8B-A10E-4B84CFC821CAQ34118123-27D609BA-6734-4FF8-ACDC-E5F901AEF2F8Q34143357-2339270D-DDE6-4C7D-A312-759375B20D5BQ34204046-783DD14C-753F-4A73-8CC2-880D9086C93AQ34230282-AA7C2D90-8375-4F66-9380-E86C667C2913Q34292324-893E1020-4C49-43D3-B41B-2EEDEA7E656DQ34590372-35780D0C-395C-4FA3-8F57-7DC5D26A78C9Q34746354-4DDE771F-07B9-4875-84D9-F816C3326E2CQ34999497-53CF6A6C-1FC7-40CA-8F3B-40C623080DB1Q35048408-FE2DC53B-A0B3-406E-B7CC-5C71869475E5Q35124859-CDADB41F-CA87-421D-BAFD-B4485DBDF026Q35133003-3DB14A51-4C9B-4D31-B66C-BE13CE8D12A2Q35171034-A945B9A3-2C4D-4951-98D9-C5B60DE0293EQ35235736-F6612444-3F3F-49EE-9363-8FDD7D968275Q35602688-1432A4F0-1607-4A4C-ACB8-34A41F09D54BQ35754166-A438D122-C582-4278-9F2A-D96FDFBE3728Q35873795-4CC6A0BA-CBC8-4AED-966B-28D56A057D8EQ36025393-3685F4B4-C06D-495C-8755-124DFB9F65B2Q36128547-168880D3-FAF2-4FA9-9939-DE148A9FD29AQ36131077-2261C9C6-2527-4F61-AA9C-28FA0331B05A
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Adenosine A3 receptor stimulation and cerebral ischemia
@ast
Adenosine A3 receptor stimulation and cerebral ischemia
@en
type
label
Adenosine A3 receptor stimulation and cerebral ischemia
@ast
Adenosine A3 receptor stimulation and cerebral ischemia
@en
prefLabel
Adenosine A3 receptor stimulation and cerebral ischemia
@ast
Adenosine A3 receptor stimulation and cerebral ischemia
@en
P2093
P2860
P1476
Adenosine A3 receptor stimulation and cerebral ischemia
@en
P2093
D K Von Lubitz
M F Carter
P2860
P356
10.1016/0014-2999(94)90523-1
P407
P577
1994-09-01T00:00:00Z